Opin vísindi

Fletta eftir efnisorði "BRCA1"

Fletta eftir efnisorði "BRCA1"

Röðun: Raða: Niðurstöður:

  • Arason, Adalgeir; Agnarsson, Bjarni A.; Jóhannesdóttir, Gudrún; Jóhannsson, Óskar Þór; Hilmarsdóttir, Bylgja; Reynisdóttir, Inga; Barkardottir, Rosa Bjork (MDPI AG, 2019-11-01)
    Mutations in BRCA1 result in predisposal to breast and ovarian cancers, but many variants exist with unknown clinical significance (VUS). One is BRCA1 c.4096+3A>G, which affects production of the full-length BRCA1 transcript, while augmenting transcripts ...
  • Stefánsdóttir, Vigdís (University of Iceland, School of Health Sciences, Faculty of Medicine, 2019-09)
    The overall aim of this PhD thesis was to cohesively assess the availability and use of electronic genealogy databases and information from cancer registries to construct electronically generated pedigrees for risk assessment in genetic counselling. ...
  • Page, Elizabeth C.; Bancroft, Elizabeth K.; Brook, Mark N.; Assel, Melissa; Hassan Al Battat, Mona; Thomas, Sarah; Taylor, Natalie; Chamberlain, Anthony; Pope, Jennifer; Raghallaigh, Holly Ni; Evans, D. Gareth; Rothwell, Jeanette; Maehle, Lovise; Grindedal, Eli Marie; James, Paul; Mascarenhas, Lyon; McKinley, Joanne; Side, Lucy; Thomas, Tessy; van Asperen, Christi; Vasen, Hans; Kiemeney, Lambertus A.; Ringelberg, Janneke; Jensen, Thomas Dyrsø; Osther, Palle J.S.; Helfand, Brian T.; Genova, Elena; Oldenburg, Rogier A.; Cybulski, Cezary; Wokolorczyk, Dominika; Ong, Kai-Ren; Huber, Camilla; Lam, Jimmy; Taylor, Louise; Salinas, Monica; Feliubadaló, Lidia; Oosterwijk, Jan C.; van Zelst-Stams, Wendy; Cook, Jackie; Rosario, Derek J.; Domchek, Susan; Powers, Jacquelyn; Buys, Saundra; O'Toole, Karen; Ausems, Margreet G.E.M.; Schmutzler, Rita K.; Rhiem, Kerstin; Izatt, Louise; Tripathi, Vishakha; Teixeira, Manuel R.; Cardoso, Marta; Foulkes, William D.; Aprikian, Armen; van Randeraad, Heleen; Davidson, Rosemarie; Longmuir, Mark; Ruijs, Mariëlle W.G.; Helderman van den Enden, Apollonia T.J.M.; Adank, Muriel; Williams, Rachel; Andrews, Lesley; Murphy, Declan G.; Halliday, Dorothy; Walker, Lisa; Liljegren, Annelie; Carlsson, Stefan; Azzabi, Ashraf; Jobson, Irene; Morton, Catherine; Shackleton, Kylie; Snape, Katie; Hanson, Helen; Harris, Marion; Tischkowitz, Marc; Taylor, Amy; Kirk, Judy; Susman, Rachel; Chen-Shtoyerman, Rakefet; Spigelman, Allan; Pachter, Nicholas; Ahmed, Munaza; Ramon y Cajal, Teresa; Zgajnar, Janez; Brewer, Carole; Gadea, Neus; Brady, Angela F.; van Os, Theo; Gallagher, David; Johannsson, Oskar; Donaldson, Alan; Barwell, Julian; Nicolai, Nicola; Friedman, Eitan; Obeid, Elias; Greenhalgh, Lynn; Murthy, Vedang; Copakova, Lucia; Saya, Sibel; McGrath, John; Cooke, Peter; Rønlund, Karina; Richardson, Kate; Henderson, Alex; Teo, Soo H.; Arun, Banu; Kast, Karin; Dias, Alexander; Aaronson, Neil K.; Ardern-Jones, Audrey; Bangma, Chris H.; Castro, Elena; Dearnaley, David; Eccles, Diana M.; Tricker, Karen; Eyfjörð, Jórunn Erla; Falconer, Alison; Foster, Christopher; Gronberg, Henrik; Hamdy, Freddie C.; Stefansdottir, Vigdis; Khoo, Vincent; Lindeman, Geoffrey J.; Lubinski, Jan; Axcrona, Karol; Mikropoulos, Christos; Mitra, Anita; Moynihan, Clare; Rennert, Gadi; Suri, Mohnish; Wilson, Penny; Dudderidge, Tim; Offman, Judith; Kote-Jarai, Zsofia; Vickers, Andrew; Lilja, Hans; Eeles, Rosalind A. (Elsevier BV, 2019-12)
    Background: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. Objective: To ...